Celanese Corporation (CE) - Total Liabilities
Based on the latest financial reports, Celanese Corporation (CE) has total liabilities worth $17.25 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Celanese Corporation - Total Liabilities Trend (2001–2025)
This chart illustrates how Celanese Corporation's total liabilities have evolved over time, based on quarterly financial data. See Celanese Corporation (CE) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Celanese Corporation Competitors by Total Liabilities
The table below lists competitors of Celanese Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
APL Apollo Tubes Limited
NSE:APLAPOLLO
|
India | Rs35.37 Billion |
|
Strathcona Resources Ltd.
TO:SCR
|
Canada | CA$4.41 Billion |
|
Corcept Therapeutics Incorporated
NASDAQ:CORT
|
USA | $176.89 Million |
|
Renk Group AG
XETRA:R3NK
|
Germany | €1.22 Billion |
|
Kite Realty Group Trust
NYSE:KRG
|
USA | $3.47 Billion |
|
BRF S.A
SA:BRFS3
|
Brazil | R$46.19 Billion |
|
CNOOC Energy Technology & Services Ltd
SHG:600968
|
China | CN¥17.98 Billion |
|
China Coal Energy Company Limited
F:CVV
|
Germany | €169.68 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Celanese Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CE market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Celanese Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Celanese Corporation (2001–2025)
The table below shows the annual total liabilities of Celanese Corporation from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $17.22 Billion | -0.14% |
| 2024-12-31 | $17.25 Billion | -9.44% |
| 2023-12-31 | $19.05 Billion | -5.56% |
| 2022-12-31 | $20.17 Billion | +171.13% |
| 2021-12-31 | $7.44 Billion | +6.05% |
| 2020-12-31 | $7.01 Billion | +6.63% |
| 2019-12-31 | $6.58 Billion | +10.85% |
| 2018-12-31 | $5.93 Billion | -4.89% |
| 2017-12-31 | $6.24 Billion | +16.92% |
| 2016-12-31 | $5.34 Billion | -7.31% |
| 2015-12-31 | $5.76 Billion | +0.30% |
| 2014-12-31 | $5.74 Billion | -9.16% |
| 2013-12-31 | $6.32 Billion | -14.93% |
| 2012-12-31 | $7.43 Billion | +3.50% |
| 2011-12-31 | $7.18 Billion | -2.45% |
| 2010-12-31 | $7.36 Billion | -5.99% |
| 2009-12-31 | $7.83 Billion | +12.09% |
| 2008-12-31 | $6.98 Billion | -0.13% |
| 2007-12-31 | $6.99 Billion | -0.61% |
| 2006-12-31 | $7.03 Billion | -1.57% |
| 2005-12-31 | $7.15 Billion | +2.03% |
| 2004-12-31 | $7.00 Billion | +66.21% |
| 2003-12-31 | $4.21 Billion | -2.48% |
| 2002-12-31 | $4.32 Billion | +1.01% |
| 2001-12-31 | $4.28 Billion | -- |
About Celanese Corporation
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more